108 related articles for article (PubMed ID: 11156482)
1. Effect of chemotherapy on ascorbate and ascorbyl radical in cerebrospinal fluid and serum of acute lymphoblastic leukemia.
Nakagawa K
Cell Mol Biol (Noisy-le-grand); 2000 Dec; 46(8):1375-81. PubMed ID: 11156482
[TBL] [Abstract][Full Text] [Related]
2. Detection and analyses of ascorbyl radical in cerebrospinal fluid and serum of acute lymphoblastic leukemia.
Nakagawa K; Kanno H; Miura Y
Anal Biochem; 1997 Dec; 254(1):31-5. PubMed ID: 9398342
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children.
Osterlundh G; Kjellmer I; Lannering B; Rosengren L; Nilsson UA; Márky I
Pediatr Blood Cancer; 2008 Apr; 50(4):793-8. PubMed ID: 17973312
[TBL] [Abstract][Full Text] [Related]
4. Folate homeostasis in cerebrospinal fluid during therapy for acute lymphoblastic leukemia.
Cole PD; Beckwith KA; Vijayanathan V; Roychowdhury S; Smith AK; Kamen BA
Pediatr Neurol; 2009 Jan; 40(1):34-41. PubMed ID: 19068252
[TBL] [Abstract][Full Text] [Related]
5. Extracellular reduction of the ascorbate free radical by human erythrocytes.
May JM; Qu Zc; Cobb CE
Biochem Biophys Res Commun; 2000 Jan; 267(1):118-23. PubMed ID: 10623584
[TBL] [Abstract][Full Text] [Related]
6. Effect of the type of serum in the medium on sodium ascorbate-induced cytotoxicity.
Sakagami H; Satoh K; Sugaya K; Iida M; Hirota N; Matsumoto K; Kimura S; Gomi K; Taguchi S; Kato S; Takeda M
Anticancer Res; 1996; 16(4A):1937-41. PubMed ID: 8712724
[TBL] [Abstract][Full Text] [Related]
7. Level of tau protein in children treated for acute lymphoblastic leukemia.
Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
[TBL] [Abstract][Full Text] [Related]
8. Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy.
Peng CT; Wu KH; Lan SJ; Tsai JJ; Tsai FJ; Tsai CH
Eur J Cancer; 2005 May; 41(8):1158-63. PubMed ID: 15911239
[TBL] [Abstract][Full Text] [Related]
9. Lumbar spinal fluid collections in children treated with intrathecal chemotherapy: elevated CSF protein as a diagnostic clue.
Almanjomi F; Armstrong D; Abla O; Naqvi A; Weitzman S; Hitzler J
Pediatr Blood Cancer; 2008 Aug; 51(2):295-8. PubMed ID: 18454469
[TBL] [Abstract][Full Text] [Related]
10. MCP-1 in the cerebrospinal fluid of children with acute lymphoblastic leukemia.
Eisenkraft A; Keidan I; Bielorai B; Keller N; Toren A; Paret G
Leuk Res; 2006 Oct; 30(10):1259-61. PubMed ID: 16516290
[TBL] [Abstract][Full Text] [Related]
11. Blood concentration of ascorbyl-free radical in children with acute lymphoblastic leukemia: preliminary report.
Urasiński T; Gonet B; Gnacińska K; Peregud-Pogorzelski J; Podraza W; Fydryk J
Haematol Blood Transfus; 1990; 33():137-40. PubMed ID: 2157642
[No Abstract] [Full Text] [Related]
12. Negative correlation between cerebrospinal fluid tau protein and cognitive functioning in children with acute lymphoblastic leukemia.
Protas PT; Muszynska-Roslan K; Holownia A; Grabowska A; Wielgat P; Krawczuk-Rybak M; Braszko JJ
Pediatr Blood Cancer; 2009 Jul; 53(1):105-8. PubMed ID: 19309718
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide and ifosfamide metabolites in the cerebrospinal fluid of children.
Yule SM; Price L; Pearson AD; Boddy AV
Clin Cancer Res; 1997 Nov; 3(11):1985-92. PubMed ID: 9815588
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid oxidative stress during chemotherapy of acute lymphoblastic leukemia in children.
Protas PT; Muszynska-Roslan K; Holownia A; Krawczuk-Rybak M; Braszko JJ
Pediatr Hematol Oncol; 2010 May; 27(4):306-13. PubMed ID: 20426521
[TBL] [Abstract][Full Text] [Related]
15. Correlation of cerebrospinal fluid beta-glucuronidase activity with plasma methotrexate concentrations in leukemic children receiving high-dose methotrexate.
Vlacha V; Eliopoulou M; Haidas S; Beratis NG
Pediatr Blood Cancer; 2004 Apr; 42(4):350-6. PubMed ID: 14966832
[TBL] [Abstract][Full Text] [Related]
16. High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study.
Tedeschi A; Montillo M; Strocchi E; Cafro AM; Tresoldi E; Intropido L; Nichelatti M; Marbello L; Baratè C; Camaggi CM; Morra E
Cancer Chemother Pharmacol; 2007 May; 59(6):771-9. PubMed ID: 17256136
[TBL] [Abstract][Full Text] [Related]
17. The impact of oxidative stress levels on the clinical effectiveness of sivelestat in treating acute lung injury: an electron spin resonance study.
Matsumoto S; Shingu C; Koga H; Hidaka S; Goto K; Hagiwara S; Iwasaka H; Noguchi T; Yokoi I
J Trauma; 2010 Apr; 68(4):796-801. PubMed ID: 20065874
[TBL] [Abstract][Full Text] [Related]
18. Significance of cerebrospinal fluid sIL-2R level as a marker of CNS involvement in acute lymphoblastic leukemia.
Lee W; Kim SJ; Lee S; Kim J; Kim M; Lim J; Kim Y; Cho B; Lee EJ; Han K
Ann Clin Lab Sci; 2005; 35(4):407-12. PubMed ID: 16254256
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group.
; te Loo DM; Kamps WA; van der Does-van den Berg A; van Wering ER; de Graaf SS
J Clin Oncol; 2006 May; 24(15):2332-6. PubMed ID: 16710032
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]